Ebsteins anomaly of the tricuspid valve epidemiology and demographics: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Template:ebstein's anomaly of the tricuspid valve}} | {{Template:ebstein's anomaly of the tricuspid valve}} | ||
{{CMG}} and Claudia P. Hochberg, M.D. [mailto:chochber@bidmc.harvard.edu] | {{CMG}} and Claudia P. Hochberg, M.D. [mailto:chochber@bidmc.harvard.edu]'''Associate Editor-In-Chief:''' {{CZ}} | ||
'''Associate Editor-In-Chief:''' {{CZ}} | |||
==Overview== | ==Overview== | ||
It is a rare congenital heart disease with no gender predilection | |||
== Epidemiology and Demographics == | == Epidemiology and Demographics == | ||
===Prevalence=== | |||
*Is a rare congenital heart disease. | |||
*In developed countries, the [[prevalence]] of ebstein's anomaly of the tricuspid valve is 0.5 per 100,000 live births. | |||
*Higher incidence in infants whose mothers are treated with [[Lithium]] Carbonate during pregnancy | |||
===Incidence=== | |||
In United States, the [[incidence]] of Ebstein" anomaly of the tricuspid valve is 5 per 100,000 patients. | |||
===Gender=== | |||
*Males = females. | *Males = females. | ||
===Race=== | |||
More common in white children. | |||
==References== | ==References== |
Revision as of 21:03, 19 October 2012
Ebsteins anomaly of the tricuspid valve Microchapters | |
Diagnosis | |
---|---|
Treatment | |
Case Studies | |
Ebsteins anomaly of the tricuspid valve epidemiology and demographics On the Web | |
American Roentgen Ray Society Images of Ebsteins anomaly of the tricuspid valve epidemiology and demographics | |
FDA on Ebsteins anomaly of the tricuspid valve epidemiology and demographics | |
CDC on Ebsteins anomaly of the tricuspid valve epidemiology and demographics | |
Ebsteins anomaly of the tricuspid valve epidemiology and demographics in the news | |
Blogs on Ebsteins anomaly of the tricuspid valve epidemiology and demographics | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] and Claudia P. Hochberg, M.D. [2]Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [3]
Overview
It is a rare congenital heart disease with no gender predilection
Epidemiology and Demographics
Prevalence
- Is a rare congenital heart disease.
- In developed countries, the prevalence of ebstein's anomaly of the tricuspid valve is 0.5 per 100,000 live births.
- Higher incidence in infants whose mothers are treated with Lithium Carbonate during pregnancy
Incidence
In United States, the incidence of Ebstein" anomaly of the tricuspid valve is 5 per 100,000 patients.
Gender
- Males = females.
Race
More common in white children.